Krsek has converted his loan to equity in Carebot, a Czech med-tech startup specializing in AI solutions for medical imaging, signifying confidence in the company's growth potential within the rapidly evolving healthcare technology sector.

Information on the Target

Carebot is a pioneering Czech med-tech startup founded in 2021 by Daniel Kvak, Karolína Kvaková, and Matěj Misař. The company specializes in developing artificial intelligence (AI) solutions aimed at enhancing the interpretation of medical imaging, starting with chest X-rays. These tools are designed to assist healthcare professionals by improving diagnostic accuracy and operational efficiency, particularly for identifying subtle abnormalities that may be overlooked by human observers.

Currently, Carebot's AI system is in use across more than one hundred hospitals in seven European countries, including the Czech Republic, Slovakia, Poland, Hungary, Germany, Bulgaria, and Greece. The platform processes over one million images annually and claims an impressive accuracy rate of up to 95% in its evaluations. With a recent market entry in March 2024 following certification, Carebot has begun generating revenues in the hundreds of thousands of euros, though it is still operating at a loss.

Industry Overview in the Czech Republic

The med-tech industry in the Czech Republic is experiencing significant growth, driven by innovations in technology and a rising demand for advanced healthcare solutions. The government actively supports the healthcare sector's modernization t